Insulin Resistance in Non-Obese Patients: The “Metabolically Obese Normal Weight” Paradox

Insulin Resistance in Non-Obese Patients: The "Metabolically Obese Normal Weight” Paradox Review Abstract Normal body mass index (BMI) has long been used as a convenient and widely accepted screening tool for assessing overweight, obesity, and cardiometabolic risk. Although BMI remains valuable for population level surveillance and initial clinical

Ozempic Nation: Paradigm Shift or Public Health Mirage?

Ozempic Nation Paradigm Shift or Public Health Mirage Review Abstract The emergence of glucagon-like peptide-1 (GLP-1) receptor agonists and related incretin-based therapies has transformed the management of obesity and type 2 diabetes mellitus. Semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, initiated a major shift in

Type 2 Diabetes Mellitus: Cellular Mechanisms, Reductionist Pitfalls, and Evidence-Based Prevention

Type 2 Diabetes Mellitus as a Multifactorial Cardiometabolic Disease: Cellular Mechanisms, Reductionist Pitfalls, and Evidence-Based Prevention Narrative Review Abstract Type 2 diabetes mellitus (T2DM) is a progressive, heterogeneous, multi-organ metabolic disease characterized by chronic hyperglycemia arising from inadequate insulin secretion relative to metabolic demand, usually

Resistant Starch and Short-Chain Fatty Acids: A Comprehensive Review of Physiologic Mechanisms

Resistant Starch and Short-Chain Fatty Acids: A Comprehensive Review of Physiologic Mechanisms and Clinical Relevance Comprehensive Guide   Abstract Resistant starch represents a distinct category of dietary carbohydrate that escapes digestion in the small intestine and undergoes fermentation by colonic bacteria. This process generates short-chain fatty

Mind, Body & Immunity: 60 Psychological Insights Into How Mental Health Influences Physical Health

Mind, Body & Immunity: 60 Psychological Insights Into How Mental Health Influences Physical Health   Abstract This paper examines the relationship between psychological states and physical health outcomes through an analysis of 60 evidence-based insights. The research draws from current studies in psychoneuroimmunology, behavioral

GLP-1 Agonists for Obesity in Non-Diabetic Patients: Game Changer or Overhyped? A Critical Analysis

GLP-1 Agonists for Obesity in Non-Diabetic Patients: Game Changer or Overhyped? A Critical Analysis Please like and subscribe if you enjoyed this video :-)    Abstract The treatment landscape for managing weight in non-diabetic patients has changed dramatically with the introduction of

Insulin Resistance in Non-Obese Patients: The “Metabolically Obese Normal Weight” Paradox